Geospatial immune variability illuminates differential evolution of lung adenocarcinoma

Journal: Nature Medicine

Published: 2020-05-27

DOI: 10.1038/s41591-020-0900-x

Affiliations: 56

Authors: 278

Go to article
Institutions Share
UCL, United Kingdom (UK) 0.15
University College London Hospitals NHS Foundation Trust (UCLH), United Kingdom (UK) 0.10
The Francis Crick Institute, United Kingdom (UK) 0.09
Wythenshawe Hospital, MFT, United Kingdom (UK) 0.07
Royal Brompton and Harefield NHS Foundation Trust, United Kingdom (UK) 0.07
Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom (UK) 0.06
University of Leicester, United Kingdom (UK) 0.04
University Hospitals Birmingham NHS Foundation Trust (UHB), United Kingdom (UK) 0.04
Aberdeen Royal Infirmary, NHS Grampian, United Kingdom (UK) 0.03
Cancer Research UK and UCL Cancer Trials Centre (UCL CTC), United Kingdom (UK) 0.03
University Hospitals of Leicester NHS Trust (UHL), United Kingdom (UK) 0.03
CRUK Lung Cancer Centre of Excellence, United Kingdom (UK) 0.03
Manchester Cancer Research Centre (MCRC), United Kingdom (UK) 0.02
Cardiff & Vale University Health Board, United Kingdom (UK) 0.02
Barts Health NHS Trust, United Kingdom (UK) 0.02
Golden Jubilee National Hospital, NHSGGC, United Kingdom (UK) 0.02
University Hospital Southampton NHS Foundation Trust, United Kingdom (UK) 0.02
The Institute of Cancer Research (ICR), United Kingdom (UK) 0.01
The Christie NHS Foundation Trust, United Kingdom (UK) 0.01
Cancer Research UK Manchester Institute, UoM, United Kingdom (UK) 0.01
Princess Alexandra Hospital NHS Trust, United Kingdom (UK) 0.01
The University of Manchester (UoM), United Kingdom (UK) 0.01
NHS Greater Glasgow and Clyde (NHSGGC), United Kingdom (UK) 0.01
Liverpool Heart and Chest Hospital, United Kingdom (UK) 0.01
Independent Cancer Patients' Voice (ICPV), United Kingdom (UK) 0.01
Barnet and Chase Farm Hospitals NHS Trust, United Kingdom (UK) 0.01
Ashford and St Peter's Hospitals NHS Foundation Trust, United Kingdom (UK) 0.01
Eötvös Loránd University (ELTE), Hungary 0.01
The Whittington Hospital, Whittington Health NHS, United Kingdom (UK) 0.01
NIHR Leicester Respiratory Biomedical Research Unit (BRU), United Kingdom (UK) 0.01
MRC Toxicology Unit, University of Cambridge, United Kingdom (UK) 0.01
Peter MacCallum Cancer Centre (Peter Mac), Australia 0
The University of Melbourne (UniMelb), Australia 0
University College Hospital (UCH), United Kingdom (UK) 0
The Royal Marsden Hospital - London, The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0
Velindre Cancer Centre, Velindre NHS Trust, United Kingdom (UK) 0
Royal Liverpool University Hospital, The Royal Liverpool and Broadgreen University Hospitals NHS Trust, United Kingdom (UK) 0
Danish Cancer Society, Denmark 0
Glenfield Hospital, United Kingdom (UK) 0
GZA Hospitals, Belgium 0
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0
Netherlands Cancer Institute (NKI), Netherlands 0
Brigham and Women's Hospital (BWH), United States of America (USA) 0
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0
Max Delbrück Center for Molecular Medicine (MDC), Germany 0
DKTK Partner Site Berlin, Germany 0

Return